Breaking Barriers in Neurodegenerative Disease Treatment
At Vertero, our mission is to change the perception and treatment of neurodegenerative diseases to delay disease progression and preserve quality of life for patients as long as possible.
Our Potential
Neurodegenerative diseases like Parkinson’s disease (PD) impart a tremendous burden to affected individuals and their loved ones.
Vertero is targeting brain diseases at the source to identify new connections that drive the development and progression of these diseases.
Our Innovation
Pioneering science beyond the brain to address upstream drivers of challenging neurodegenerative diseases.
With an unorthodox mindset and data-driven innovation, we are designing oral therapeutics that precisely modulate peripheral targets known to accelerate brain disease to disrupt the course of the disease at the source.
Our lead candidate, VT-5006, is designed to precisely treat a validated target in the gut that feeds the protein aggregation and inflammation that drives Parkinson’s disease.
With ingenuity, rigor, and persistence, we believe we can turn the prospects for patients and change the way people think about treating neurodegenerative diseases.